A Cure for Multiple Sclerosis? Scientists Say Within Our Lifetime
WEBJun 12, 2024 · A generation ago, a diagnosis of multiple sclerosis was a guarantee of a debilitating disease that would leave the patient wheelchair bound, and worse. Follow UCSF’s role in what some call the golden age of MS research and care.
Research News and Progress for MS | National MS Society
WEBStay informed on the latest breakthroughs and developments in MS research and discover the historical milestones we have made in research progress for MS.
Could this new drug turn back the clock on multiple sclerosis?
WEBMultiple sclerosis (MS) degrades the protective insulation around nerve cells, leaving their axons, which carry electrical impulses, exposed like bare wires. This can cause devastating...
Multiple Sclerosis Research News - ScienceDaily
WEBAug 26, 2024 · Information on multiple sclerosis. Read current research articles and learn about multiple sclerosis diagnosis, symptoms as well as the latest MS treatment options.
CAR-T therapy for multiple sclerosis enters US trials for ... - Nature
WEBFeb 22, 2024 · The first US trials of engineered cells to treat multiple sclerosis have started recruiting volunteers, raising hopes for a new therapeutic option for this devastating neurodegenerative disease...
Multiple sclerosis - Latest research and news | Nature
WEBSep 12, 2024 · Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. Latest...
Could What Makes Multiple Sclerosis Worse Lead to a Cure?
WEBJun 28, 2023 · A study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression that can rob patients of their mobility and independence over time.
'Major moment in MS research' as new Octopus trial starts - BBC
WEBApr 4, 2023 · The Octopus trial - so-called because it is a multi-arm, multi-stage trial - is being run by Prof Jeremy Chataway, from the National Hospital for Neurology and Neurosurgery UCLH in London, with £...
Refined Pathways to Cures Roadmap Published in Multiple Sclerosis ...
WEB[September 3, 2024] – The Multiple Sclerosis Journal has published the next iteration of The Pathways to Cures Roadmap, which outlines research areas with the greatest potential to stop MS, restore function and repair damage from the disease, and end MS through prevention. The updated Roadmap accounts for recent scientific advances and provides recommendations which could accelerate progress ...
MS-STAT2 trial shows that simvastatin is not an ... - MS Society UK
WEB2 days ago · Part-funded by the MS Society, the phase 3 MS-STAT2 trial tested simvastatin – commonly used to treat high cholesterol – in 964 people with secondary progressive MS. MS-STAT2 built on encouraging results from an earlier phase 2 trial.